Morning Briefing
Summaries of health policy coverage from major news organizations
IOM Proposes State, FDA Actions To Stop Growth Of Counterfeit Drugs
The Institute of Medicine Wednesday urged a series regulatory changes to help protect the public against buying fake or poorly made drugs.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
